Volgen
Nathan Sepeda
Nathan Sepeda
Johns Hopkins School of Medicine
Geverifieerd e-mailadres voor jh.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial
AK Davis, FS Barrett, DG May, MP Cosimano, ND Sepeda, MW Johnson, ...
JAMA psychiatry 78 (5), 481-489, 2021
12062021
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
N Gukasyan, AK Davis, FS Barrett, MP Cosimano, ND Sepeda, ...
Journal of Psychopharmacology 36 (2), 151-158, 2022
3442022
Emotions and brain function are altered up to one month after a single high dose of psilocybin
FS Barrett, MK Doss, ND Sepeda, JJ Pekar, RR Griffiths
Scientific reports 10 (1), 2214, 2020
3432020
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
MK Doss, M Považan, MD Rosenberg, ND Sepeda, AK Davis, PH Finan, ...
Translational psychiatry 11 (1), 574, 2021
2522021
People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences
MT Williams, AK Davis, Y Xin, ND Sepeda, PC Grigas, S Sinnott, ...
Drugs: Education, Prevention and Policy 28 (3), 215-226, 2021
1252021
Psychedelic treatment for trauma-related psychological and cognitive impairment among US special operations forces veterans
AK Davis, LA Averill, ND Sepeda, JP Barsuglia, T Amoroso
Chronic Stress 4, 2470547020939564, 2020
792020
Increases in psychological flexibility mediate relationship between acute psychedelic effects and decreases in racial trauma symptoms among people of color
AK Davis, Y Xin, ND Sepeda, A Garcia-Romeu, MT Williams
Chronic Stress 5, 24705470211035607, 2021
482021
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
SM Nayak, H Jackson, ND Sepeda, DS Mathai, S So, A Yaffe, H Zaki, ...
Frontiers in Psychiatry 14, 1199642, 2023
422023
Inhaled 5-methoxy- N , N -dimethyltryptamine: Supportive context associated with positive acute and enduring effects
ND Sepeda, JM Clifton, LY Doyle, R Lancelotta, RR Griffiths, AK Davis
Journal of Psychedelic Studies 4 (2), 114-122, 2020
242020
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial …
AW Levin, R Lancelotta, ND Sepeda, N Gukasyan, S Nayak, TL Wagener, ...
PloS one 19 (3), e0300501, 2024
222024
Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans
SB Armstrong, Y Xin, ND Sepeda, M Polanco, LA Averill, AK Davis
Military psychology 36 (2), 184-191, 2024
122024
Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in …
AK Davis, Y Xin, N Sepeda, LA Averill
The American Journal of Drug and Alcohol Abuse 49 (5), 587-596, 2023
102023
Predictors of psychedelic treatment outcomes among special operations forces veterans.
Y Xin, SB Armstrong, LA Averill, N Sepeda, AK Davis
Psychology of Consciousness: Theory, Research, and Practice, 2023
52023
Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use
DS Mathai, DE Roberts, SM Nayak, ND Sepeda, A Lehrner, MW Johnson, ...
Journal of Psychoactive Drugs, 1-12, 2025
32025
Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study
G Jones, MX Lowe, S Nayak, N Sepeda, H Kettner, R Carhart-Harris, ...
Journal of Affective Disorders 370, 54-61, 2025
22025
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences
AK Davis, C Timmermann, AM Ortiz Bernal, R Lancelotta, S Nayak, ...
Journal of psychoactive drugs 56 (4), 456-466, 2024
22024
Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal Survey
J Richard, S Nayak, N Sepeda, A Garcia-Romeu
Drug and Alcohol Dependence 267, 112184, 2025
2025
The Epidemiology of Psychedelic Use Among United States Military Veterans
AK Davis, M Bates, EM Lund, ND Sepeda, AW Levin, SB Armstrong, ...
Journal of Psychoactive Drugs, 1-14, 2024
2024
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–18